Usina Pharm SRL
1.3 FTEUsina Pharm reported total assets of €3.22m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026), with 1.3 full-time equivalent.
The score of Usina Pharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +58 % Total assets +7 % Headcount (avg FTE) -35 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Usina Pharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Usina Pharm's financial analysis
- Solvency62.5%sector median: 50.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Usina Pharm
Usina Pharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0553.961.456
- VAT number
- BE0553961456
- Peppol
- Registered · 0208:0553961456 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jun 2014
- Registered office
- 7041 Quévy
- Size
- Micro · 1.3 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Machining of metals (NACE 25530)
Usina Pharm (SRL) has been based in Quévy since 2014, active in: machining of metals. For 2025, it reports a net profit of 349,643 € and equity of €2.01m; its revenue is not published. With 1.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 62.5%, above the median of its sector (50.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Usina Pharm
Companies in the same business, of comparable size and area, outside its group.
- S.A. Leyskens Machining of metals Herstal · balance sheet €3.22m
- B&L Machining of metals Lommel · balance sheet €3.79m
- Construct Hoet Machining of metals Koekelare · balance sheet €4.19m
- Facim Machining of metals Essen · balance sheet €4.24m
- WPM_Nili Machining of metals Aarschot · balance sheet 26,280 €
- Bontemps & C° Machining of metals Vilvoorde · balance sheet €3.02m
- Clim ' Max Machining of metals Roeselare · balance sheet €3.56m
- De Machine Fabriek Kasterlee Machining of metals Kasterlee · balance sheet €4.58m
Frequently asked questions about Usina Pharm
What is the revenue of Usina Pharm?
Usina Pharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Usina Pharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0553961456 for Usina Pharm, if the company is VAT-registered. Its company number (CBE) is 0553.961.456.
Where is the registered office of Usina Pharm?
According to the CBE register, the registered office of Usina Pharm is in 7041 Quévy.
What is the equity of Usina Pharm?
At the close of the 2025 financial year, the equity of Usina Pharm amounts to 2,013,688 €, a solvency of 62.5% of total assets.
How many people work at Usina Pharm?
1.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Usina Pharm?
The register lists 2 active mandates at Usina Pharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Usina Pharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →